Prevalence of hepatitis C serum antibody in autoimmune diseases

Journal of Autoimmunity

Volumn 32, Issue 3-4, 2009, Pages 261-266

  Agmon Levin, Nancy ^a   Ram, Maya ^a   Barzilai, Ori ^a   Porat Katz, Bat sheva ^b   Parikman, Ronit ^a   Selmi, Carlo ^c   Eric Gershwin, M ^d   Anaya, Juan Manuel ^e   Youinou, Pierre ^f   Bizzaro, Nicola ^g   Tincani, Angela ^h   Tzioufas, Athanasios G ⁱ   Cervera, Ricard ^j   Stojanovich, Ljudmila ^k   Martin, Javier ^l   Gonzalez Gay, Miguel Angel ^m   Valentini, Gabriele ⁿ   Blank, Miri ^a   SanMarco, Marielle ^o   Rozman, Blaž ^p   Bombardieri, Stefano ⁿ   De Vita, Salvatore ^q   Shoenfeld, Yehuda ^a,r   more..

^a SHEBA MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c UNIVERSITY OF MILAN   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSIDAD DEL ROSARIO   (Colombia)

^f BREST UNIVERSITY HOSPITAL   (France)

^g Ospedale Civile   (Italy)

^h UNIVERSITY OF BRESCIA   (Italy)

ⁱ UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^j HOSPITAL CLÍNIC   (Spain)

^k UNIVERSITY OF BELGRADE   (Serbia)

^l UNIVERSITY OF PISA   (Italy)

^m HOSPITAL XERAL CALDE   (Spain)

ⁿ SECOND UNIVERSITY OF NAPLES   (Italy)

^o HÔPITAL DE LA CONCEPTION   (France)

^p UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^q UNIVERSITY OF UDINE   (Italy)

^r TEL AVIV UNIVERSITY   (Israel)

more..

Author keywords

Antiphospholipids syndrome; Autoantibodies; Autoimmune diseases; Cryoglobulinemia; Hepatitis C; Inflammatory bowel diseases; Pemphigus vulgaris; Thyroid autoimmune diseases

Indexed keywords

AUTOANTIBODY; CYTOMEGALOVIRUS ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS C ANTIBODY; PROTOZOON ANTIBODY;

ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CHURG STRAUSS SYNDROME; CONTROLLED STUDY; CRYOGLOBULINEMIA; DIABETES MELLITUS; ENTERITIS; GIANT CELL ARTERITIS; HASHIMOTO DISEASE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MICROSCOPIC POLYANGIITIS; MULTIPLE SCLEROSIS; MYOSITIS; PEMPHIGUS VULGARIS; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXOPLASMA GONDII; WEGENER GRANULOMATOSIS;

AGED; AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; PREVALENCE;

EID: 67349203916     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2009.02.017     Document Type: Article

References (77)

1. Barzilai O., Sherer Y., Ram M., Izhaky D., Anaya J.M., and Shoenfeld Y. Epstein-Barr virus and cytomegalovirus in autoimmune diseases: are they truly notorious? A preliminary report. Ann N Y Acad Sci 1108 (2007) 567-577
2. Shoenfeld Y., Zandman-Goddard G., Stojanovich L., et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases-2008. Isr Med Assoc J 10 1 (2008) 8-12
3. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., and Rose N.R. From infection to autoimmunity. J Autoimmun 16 3 (2001) 175-186
4. Fujinami R.S. Can virus infections trigger autoimmune disease?. J Autoimmun 16 3 (2001) 229-234
5. Bach J.F. Infections and autoimmune diseases. J Autoimmun 25 Suppl (2005) 74-80
6. Ramos-Casals M., De Vita S., and Tzioufas A.G. Hepatitis C virus, Sjögren's syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer. Autoimmun Rev 4 1 (2005) 8-15
7. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 1 (2001) 41-52
8. Craxi A., Laffi G., and Zignego A.L. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med 29 1-2 (2008) 85-95
9. Shepard C.W., Finelli L., and Alter M.J. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5 9 (2005) 558-567
10. Modi A.A., and Liang T.J. Hepatitis C: a clinical review. Oral Dis 14 1 (2008) 10-14
11. Zignego A.L., Ferri C., Pileri S.A., Caini P., and Bianchi F.B. Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis 39 1 (2007) 2-17
12. Giordano T.P., Henderson L., Landgren O., et al. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. Jama 297 18 (2007) 2010-2017
13. Ahmed M.M., Berney S.M., Wolf R.E., et al. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus. Am J Med Sci 331 5 (2006) 252-256
14. Ferri S., Muratori L., Lenzi M., Granito A., Bianchi F.B., and Vergani D. HCV and autoimmunity. Curr Pharm Des 14 17 (2008) 1678-1685
15. McMurray R.W., and Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 26 4 (1997) 689-701
16. Sene D., Piette J.C., and Cacoub P. Antiphospholipid antibodies, antiphospholipid syndrome and infections. Autoimmun Rev 7 4 (2008) 272-277
17. Bianchi F.B., Muratori P., Granito A., Pappas G., Ferri S., and Muratori L. Hepatitis C and autoreactivity. Dig Liver Dis 39 Suppl. 1 (2007) S22-S24
18. Agarwal N., Handa R., Acharya S.K., Wali J.P., Dinda A.K., and Aggarwal P. A study of autoimmune markers in hepatitis C infection. Indian J Med Res 113 (2001) 170-174
19. Toubi E., Gordon S., Kessel A., et al. Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity. J Autoimmun 27 2 (2006) 134-139
20. Ganne-Carrie N., Medini A., Coderc E., et al. Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case-control study. J Autoimmun 14 2 (2000) 189-193
21. Lormeau C., Falgarone G., Roulot D., and Boissier M.C. Rheumatologic manifestations of chronic hepatitis C infection. Joint Bone Spine 73 6 (2006) 633-638
22. Landau D.A., Saadoun D., Calabrese L.H., and Cacoub P. The pathophysiology of HCV induced B-cell clonal disorders. Autoimmun Rev 6 8 (2007) 581-587
23. Sene D., Limal N., Ghillani-Dalbin P., Saadoun D., Piette J.C., and Cacoub P. Hepatitis C virus-associated B-cell proliferation-the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford) 46 1 (2007) 65-69
24. Landau D.A., Rosenzwajg M., Saadoun D., Klatzmann D., and Cacoub P. The BLyS/BAFF receptor-ligand system in HCV induced B-cell clonal disorders. Ann Rheum Dis (2008)
25. De Vita S., Quartuccio L., and Fabris M. Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?. Autoimmun Rev 8 2 (2008) 95-99
26. Kammer A.R., van der Burg S.H., Grabscheid B., et al. Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition. J Exp Med 190 2 (1999) 169-176
27. Antonelli A., Ferri C., Fallahi P., et al. Thyroid disorders in chronic hepatitis C virus infection. Thyroid 16 6 (2006) 563-572
28. Buskila D., Shnaider A., Neumann L., et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 28 2 (1998) 107-113
29. Akeno N., Blackard J.T., and Tomer Y. HCV E2 protein binds directly to thyroid cells and induces IL-8 production: A new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 31 4 (2008) 339-344
30. Hadziyannis S.J. The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepat 4 1 (1997) 9-28
31. Vassilopoulos D., and Calabrese L.H. Rheumatic manifestations of hepatitis C infection. Curr Rheumatol Rep 5 3 (2003) 200-204
32. Pawlotsky J.M., Roudot-Thoraval F., Simmonds P., et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 122 3 (1995) 169-173
33. Cacoub P., Renou C., Rosenthal E., et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 79 1 (2000) 47-56
34. Zandman-Goddard G., Berkun Y., Barzilai O., et al. Neuropsychiatric lupus and infectious triggers. Lupus 17 5 (2008) 380-384
35. Cainelli F. Hepatitis C virus infection in the elderly: epidemiology, natural history and management. Drugs Aging 25 1 (2008) 9-18
36. Alter M.J. Epidemiology of hepatitis C virus infection. World J Gastroenterol 13 17 (2007) 2436-2441
37. Kondili L.A., Chionne P., Costantino A., et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 50 5 (2002) 693-696
38. Robinson J.W., Rosas M., Guzman F., Patarroyo M.E., and Moreno A. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations. J Med Virol 50 2 (1996) 188-192
39. Ferri C. Mixed cryoglobulinemia. Orphanet J Rare Dis 3 (2008) 25
40. Antonelli A., Ferri C., Ferrari S.M., Colaci M., and Fallahi P. Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev 8 1 (2008) 18-23
41. Saadoun D., Landau D.A., Calabrese L.H., and Cacoub P.P. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford) 46 8 (2007) 1234-1242
42. Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 1. sialadenitis and salivary glands lymphoma. Oral Dis 14 2 (2008) 123-130
43. Indolfi G., Stagi S., Bartolini E., et al. Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection. Clin Endocrinol (Oxf) 68 1 (2008) 117-121
44. Cacoub P., Renou C., Kerr G., et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44 9 (2001) 2118-2124
45. Tedeschi A., Barate C., Minola E., and Morra E. Cryoglobulinemia. Blood Rev 21 4 (2007) 183-200
46. Lidar M., Lipschitz N., Langevitz P., et al. Infectious Serologies and Autoantibodies in Wegener's Granulomatosis and other Vasculitides: Novel Associations Disclosed Using the Rad BioPlex 2200. Ann N Y Acad Sci (2009)
47. Ramos-Casals M., Forns X., and Sanchez-Tapias J.M. Extrahepatic Manifestations in Patients with Chronic Hepatitis C Virus Infection. In: Font J., Ramos-Casals M., Juan Rodé S., and Asherson R.A. (Eds). Digestive Involvement in Systemic Autoimmune Diseases (2008), Elsevier 209-228
48. Antonelli A., Ferri C., Fallahi P., et al. Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia. Qjm 97 8 (2004) 499-506
49. Antonelli A., Ferri C., Pampana A., et al. Thyroid disorders in chronic hepatitis C. Am J Med 117 1 (2004) 10-13
50. Tomer Y., and Villanueva R. Hepatitis C and thyroid autoimmunity: is there a link?. Am J Med 117 1 (2004) 60-61
51. Cassani F., Cataleta M., Valentini P., et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 26 3 (1997) 561-566
52. Garcia-Sastre A., and Biron C.A. Type 1 interferons and the virus-host relationship: a lesson in detente. Science 312 5775 (2006) 879-882
53. Krause I., Valesini G., Scrivo R., and Shoenfeld Y. Autoimmune aspects of cytokine and anticytokine therapies. Am J Med 115 5 (2003) 390-397
54. Sagi L., Sherer Y., Trau H., and Shoenfeld Y. Pemphigus and infectious agents. Autoimmun Rev 8 1 (2008) 33-35
55. Carrozzo M. Oral diseases associated with hepatitis C virus infection. Part 2: lichen planus and other diseases. Oral Dis 14 3 (2008) 217-228
56. Sherer Y., Blank M., and Shoenfeld Y. Antiphospholipid syndrome (APS): where does it come from?. Best Pract Res Clin Rheumatol 21 6 (2007) 1071-1078
57. Garcia-Carrasco M., Galarza-Maldonado C., Mendoza-Pinto C., Escarcega R.O., and Cervera R. Infections and the Antiphospholipid Syndrome. Clin Rev Allergy Immunol (2008)
58. Blank M., Asherson R.A., Cervera R., and Shoenfeld Y. Antiphospholipid syndrome infectious origin. J Clin Immunol 24 1 (2004) 12-23
59. Munoz-Rodriguez F.J., Tassies D., Font J., et al. Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome. J Hepatol 30 5 (1999) 770-773
60. Ramos-Casals M., Cervera R., Lagrutta M., et al. Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus/HIV infection): description of 82 cases. Clin Infect Dis 38 7 (2004) 1009-1016
61. Cervera R., Asherson R.A., Acevedo M.L., et al. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients. Ann Rheum Dis 63 10 (2004) 1312-1317
62. Biancone L., Pavia M., Del Vecchio Blanco G., et al. Hepatitis B and C virus infection in Crohn's disease. Inflamm Bowel Dis 7 4 (2001) 287-294
63. Lidar M, Pnina Langevitz, Ori Barzilai, et al. Infectious Serologies and Autoantibodies in Inflammatory Bowel Disease: Insinuations at a True Pathogenic Role. In Press.
64. Tilg H., Vogelsang H., Ludwiczek O., et al. A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitis. Gut 52 12 (2003) 1728-1733
65. Fox R.I. Sjögren's syndrome. Lancet 366 9482 (2005) 321-331
66. Fattovich G., Tagger A., Brollo L., et al. Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 163 2 (1991) 400-402
67. Gaeta G.B., Stornaiuolo G., Precone D.F., et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study. J Hepatol 39 6 (2003) 1036-1041
68. Park J.S., Saraf N., and Dieterich D.T. HBV plus HCV, HCV plus HIV, HBV plus HIV. Curr Gastroenterol Rep 8 1 (2006) 67-74
69. Chu C.J., and Lee S.D. Hepatitis B virus/hepatitis C virus coinfection: epidemiology, clinical features, viral interactions and treatment. J Gastroenterol Hepatol 23 4 (2008) 512-520
70. Dai C.Y., Yu M.L., Chuang W.L., et al. Influence of hepatitis C virus on the profiles of patients with chronic hepatitis B virus infection. J Gastroenterol Hepatol 16 6 (2001) 636-640
71. Xess A., Kumar M., Minz S., Sharma H.P., and Shahi S.K. Prevalence of hepatitis B and hepatitis C virus coinfection in chronic liver disease. Indian J Pathol Microbiol 44 3 (2001) 253-255
72. Tozzoli R., Barzilai O., Ram M., et al. Infections and autoimmune thyroid diseases: parallel detection of antibodies against pathogens with proteomic technology. Autoimmun Rev 8 2 (2008) 112-115
73. Buskila D., Sikuler E., and Shoenfeld Y. Hepatitis C virus, autoimmunity and rheumatic disease. Lupus 6 9 (1997) 685-689
74. Akatsuka T., Kobayashi N., Ishikawa T., et al. Autoantibody response to microsomal epoxide hydrolase in hepatitis C and A. J Autoimmun 28 1 (2007) 7-18
75. Drygiannakis D., Lionis C., Drygiannakis I., Pappas G., and Kouroumalis E. Low prevalence of liver-kidney microsomal autoantibodies of type 1 (LKM1) in hepatitis C seropositive subjects on Crete, Greece. BMC Gastroenterol 1 (2001) 4
76. Fried M.W., Draguesku J.O., Shindo M., et al. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci 38 4 (1993) 631-636
77. Shoenfeld Y., Gilburd B., Abu-Shakra M., et al. The mosaic of autoimmunity: genetic factors involved in autoimmune diseases-2008. Isr Med Assoc J 10 1 (2008) 3-7 2008